H Kearney
Overview
Explore the profile of H Kearney including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
162
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Meldrum D, Kearney H, Hutchinson S, McCarthy S, Quinn G
Front Rehabil Sci
. 2024 Jul;
5:1406926.
PMID: 39050817
Introduction: Vertigo, dizziness, gaze instability and disequilibrium are highly prevalent in people with MS (PwMS) and head movement induced dizziness is commonly reported. Vestibular physical therapy (VPT) is a specialised,...
2.
Quigley S, Yiannakas M, Bede P, Meaney J, Kearney H
Mult Scler Relat Disord
. 2023 Mar;
71:104555.
PMID: 36870314
Multiple sclerosis (MS) is frequently misdiagnosed based on MRI abnormalities detected in the brain white matter. Cortical lesions have been well described neuropathologically, but remain challenging to detect in clinical...
3.
Whelehan A, Colfer M, Kearney H, OConnell S, OConnor G, Healy D, et al.
Epilepsy Behav Rep
. 2020 Jul;
14:100375.
PMID: 32671335
Reflex epilepsies are rare syndromes where seizures are triggered by particular stimuli or activities that may be motor, sensory or cognitive in nature. Triggers are diverse, may be extrinsic or...
4.
ORegan C, Kearney H, Beausang A, Farrell M, Brett F, Cryan J, et al.
J Neurooncol
. 2017 Dec;
137(2):233-240.
PMID: 29264834
Epigenetic silencing of O-6-methylguanine-DNA methyltransferase (MGMT) promoter via methylation in a glioblastoma (GBM), has been correlated with a more favourable response to alkylating chemotherapeutic agents such as temozolomide. The use...
5.
Kearney H, Cahalane A, Killeen R, McGuigan C
Ir J Med Sci
. 2017 Nov;
187(2):499.
PMID: 29181830
The original version of this article unfortunately contained a mistake. The presentation of Table 1 was incorrectly captured. The Publisher regrets that it introduced errors to Table 1 during the...
6.
Kearney H, Cahalane A, Killeen R, McGuigan C
Ir J Med Sci
. 2017 Oct;
187(2):493-498.
PMID: 29019147
The diagnosis of multiple sclerosis (MS) is based on a history consistent with demyelination of the central nervous system and corresponding physical signs on examination. However, this diagnosis is supported...
7.
Brett F, Looby S, Chalissery A, Chen D, Heaney C, Heffernan J, et al.
Ir J Med Sci
. 2017 Aug;
187(2):515-520.
PMID: 28803271
Aims: Creutzfeldt-Jakob disease (CJD) risk precautions are required when performing brain biopsies on patients with a dementing illness and in 'risk' groups. The impact on a diagnostic neuropathology service is...
8.
Kearney H, Krakar A, Drazyk A, Maloney E, Callinan I, Tubridy N
Ir Med J
. 2016 Nov;
109(7):438.
PMID: 27834089
The aim of this audit was to determine the effectiveness of large group tutorials for teaching neurology to medical students. Students were asked to complete a questionnaire rating their confidence...
9.
Kearney H, Miszkiel K, Yiannakas M, Ciccarelli O, Miller D
Mult Scler Relat Disord
. 2015 Apr;
2(2):103-8.
PMID: 25877631
Objectives: Spinal cord pathology is a major cause of disability in multiple sclerosis (MS) and pathology studies show multifocal demyelinating lesions in white matter (WM) tracts and central grey matter...
10.
Kearney H, Schneider T, Yiannakas M, Altmann D, Wheeler-Kingshott C, Ciccarelli O, et al.
J Neurol Neurosurg Psychiatry
. 2014 Aug;
86(6):608-14.
PMID: 25097217
Background: In multiple sclerosis (MS), pathological studies have identified substantial demyelination and neuronal loss in the spinal cord grey matter (GM). However, there has been limited in vivo investigation of...